Millendo Therapeutics Sweeps Up Phase II Asset With Acquisition of Small Biotech
Millendo Therapeutics announced that it has acquired Alize Pharma SAS in a stock-based transaction. Source: BioSpace
JSR Life Sciences Snaps Up CRO in $400M Deal
The parent company of JSR Life Sciences snapped up CRO Crown Bioscience International for $400M, the company announced this morning. Source: BioSpace
Juno, Thermo Fisher Ink CAR T Manufacturing Partnership
Under the seven-year nonexclusive licensing and supply agreement, Juno has obtained rights to use CTS Dynabeads CD3/CD28 magnetic beads as part of the clinical and commercial manufacturing processes for its…
Orchard Therapeutics Scoops Up $110M in Funding to Advance "Bubble Boy Syndrome" Gene Therapy
Baillie Gifford and ORI Capital co-led the financing with significant new investments from Temasek and Cowen Healthcare Investments, alongside Juda Capital, Pavilion Capital, RTW Investments, Agent Capital, 4BIO Capital and…
FDA Unveils Risk-Based Enforcement Approach to Homeopathic Drugs
In a new policy initiative, the FDA outlined new enforcement measures for homeopathic products. Source: Drug Industry Daily
GAO Reports on Drug Pricing, R&D Changes
Retail prescription drug prices have nearly doubled since the 1990s according to a Government Accountability Office report issued Tuesday. Source: Drug Industry Daily
House Cuts Orphan Drug Credit in Half as Part of Tax Reform Bill
The House of Representatives moved closer to passing the final version of the Republicans’ tax reform legislation Tuesday, a sweeping $1.5 trillion measure that reduces or eliminates many deductions and…
FDA Closes Orphan Designation Loophole for Pediatric Subpopulations
Closing what it calls an “unintended loophole,” the FDA will no longer issue orphan drug designations for smaller pediatric subpopulations of more common diseases, unless certain criteria are met. Source:…
FDA Approves Gene Therapy for Retinal Dystrophy
The FDA approved Spark Therapeutics’ novel gene therapy to treat an inherited form of vision loss — making it the first genetic therapy approved in the U.S. to target a…
UK Watchdog Claims Concordia Overcharged for Thyroid Meds
The UK’s competition watchdog agency claimed the drugmaker Concordia overcharged the NHS by millions for its hypothyroid medication liothyronine, also known as Cytomel, following price increases of almost 6,000 percent…
- Go to the previous page
- 1
- …
- 220
- 221
- 222
- 223
- 224
- 225
- 226
- …
- 610
- Go to the next page